Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$9.59
+2.1%
$9.87
$5.47
$13.50
$389.02M0.6583,450 shs273,561 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$11.13
+0.6%
$11.61
$10.24
$20.73
$435.69M0.8288,873 shs160,793 shs
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$3.08
+0.7%
$2.84
$2.36
$4.92
$230.38M0.45752,577 shs304,101 shs
Surmodics, Inc. stock logo
SRDX
Surmodics
$29.99
+3.4%
$28.89
$26.00
$42.44
$428.83M1.31229,119 shs140,852 shs
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
$28.24
$28.24
$15.92
$28.25
$954.91M1.45351,526 shs14,512 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
0.00%-1.94%-12.50%+5.27%+68.84%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.00%+0.32%+2.06%-23.70%-17.71%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
0.00%+2.33%+6.21%-0.96%-23.57%
Surmodics, Inc. stock logo
SRDX
Surmodics
0.00%+4.08%-0.02%+2.27%-28.57%
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
3.9861 of 5 stars
3.51.00.04.22.51.70.6
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
3.0816 of 5 stars
3.52.00.00.01.43.31.3
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
1.0184 of 5 stars
1.02.00.04.20.01.70.6
Surmodics, Inc. stock logo
SRDX
Surmodics
4.2078 of 5 stars
3.33.00.03.40.91.71.9
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
3.00
Buy$14.0045.99% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
3.00
Buy$21.5093.26% Upside
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
2.00
Hold$3.00-2.60% Downside
Surmodics, Inc. stock logo
SRDX
Surmodics
2.50
Moderate Buy$43.0043.41% Upside
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ANGO, XENT, SRDX, OSUR, and OFIX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$16.00
6/6/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
5/19/2025
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingIn-Line ➝ In-Line$3.00 ➝ $3.00
4/30/2025
Surmodics, Inc. stock logo
SRDX
Surmodics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/7/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $16.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$303.91M1.28$4.30 per share2.23$5.13 per share1.87
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$799.49M0.55N/AN/A$13.07 per share0.85
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$185.83M1.24$0.04 per share79.33$5.50 per share0.56
Surmodics, Inc. stock logo
SRDX
Surmodics
$126.08M3.40$0.31 per share96.93$8.33 per share3.60
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
$106.75M8.95N/AN/A($2.06) per share-13.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$184.35M-$1.01N/AN/AN/A-14.61%-3.73%-2.43%7/15/2025 (Estimated)
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$126M-$3.69N/AN/AN/A-17.78%-28.15%-16.51%8/5/2025 (Estimated)
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
-$19.50M-$0.42N/AN/AN/A-19.77%-5.86%-5.20%8/5/2025 (Estimated)
Surmodics, Inc. stock logo
SRDX
Surmodics
-$11.54M-$1.39N/A37.48N/A-16.34%-7.10%-4.77%7/30/2025 (Estimated)
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
-$159.63M-$4.79N/AN/AN/A-161.94%-709.52%-48.18%N/A

Latest ANGO, XENT, SRDX, OSUR, and OFIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q3 2025
Surmodics, Inc. stock logo
SRDX
Surmodics
-$0.21N/AN/AN/A$28.04 millionN/A
7/15/2025Q4 2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.13N/AN/AN/A$74.26 millionN/A
4/30/2025Q2 2025
Surmodics, Inc. stock logo
SRDX
Surmodics
-$0.06-$0.13-$0.07-$0.36$32.23 million$28.09 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/AN/AN/AN/AN/A
Surmodics, Inc. stock logo
SRDX
Surmodics
N/AN/AN/AN/AN/A
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.21
1.40
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.38
2.71
1.50
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/A
12.34
10.94
Surmodics, Inc. stock logo
SRDX
Surmodics
0.27
5.14
3.99
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
6.89
1.88
1.50

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
93.50%
Surmodics, Inc. stock logo
SRDX
Surmodics
96.63%
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
92.47%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
5.40%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1.30%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
3.90%
Surmodics, Inc. stock logo
SRDX
Surmodics
8.90%
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
76040.61 million38.41 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,61639.18 million38.67 millionOptionable
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
84074.80 million71.88 millionOptionable
Surmodics, Inc. stock logo
SRDX
Surmodics
45014.30 million13.03 millionOptionable
Intersect ENT, Inc. stock logo
XENT
Intersect ENT
43333.81 million33.10 millionOptionable

Recent News About These Companies

Zee Ent. - Zee Entertainment Enterprises Share Price
Kiatnakin Bank PCL (KKP)
At the Intersection of Law & Policy
XENT Historical Data

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$9.59 +0.20 (+2.13%)
Closing price 07/3/2025 02:41 PM Eastern
Extended Trading
$9.59 0.00 (0.00%)
As of 07/3/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Orthofix Medical stock logo

Orthofix Medical NASDAQ:OFIX

$11.12 +0.07 (+0.59%)
As of 07/3/2025 01:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

OraSure Technologies stock logo

OraSure Technologies NASDAQ:OSUR

$3.08 +0.02 (+0.65%)
As of 07/3/2025 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

Surmodics stock logo

Surmodics NASDAQ:SRDX

$29.98 +0.99 (+3.40%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Intersect ENT stock logo

Intersect ENT NASDAQ:XENT

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.